Coccidioidomycosis screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]
Overview
Overview
It is important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.
Screening
Screening
Coccidioidomycosis is often mistaken for community acquired pneumonia(CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.[1]
References
References
- ↑ Chang, DC.; Anderson, S.; Wannemuehler, K.; Engelthaler, DM.; Erhart, L.; Sunenshine, RH.; Burwell, LA.; Park, BJ. “Testing for coccidioidomycosis among patients with community-acquired pneumonia”. Emerg Infect Dis. 14 (7): 1053–9. doi:10.3201/eid1407.070832. PMID 18598625.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH